These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 797084)

  • 21. The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).
    Persson I
    Eur J Clin Pharmacol; 1977 Jul; 11(6):419-21. PubMed ID: 330169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

  • 23. Pindolol in hypertension: a double-blind trial.
    Feltham PM; Watson OF; Peel JS; Dunlop DJ; Turner AS
    N Z Med J; 1972 Sep; 76(484):167-71. PubMed ID: 4564997
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy of single-daily-dose pindolol in arterial hypertension].
    Thomas J; Pierredon M; Sankale M
    Therapie; 1978; 33(6):797-804. PubMed ID: 371062
    [No Abstract]   [Full Text] [Related]  

  • 25. Once-a-day treatment of hypertension with pindolol.
    Frithz G
    Am Heart J; 1982 Aug; 104(2 Pt 2):413-6. PubMed ID: 7102526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pindolol in arterial hypertension. Multicentric study with 15 mg. of Viskene (pindolol) in a single daily dose].
    Abetel G; Christeler P; Henry M; Karly M; Knobel P; Magnenat G; Morandi D; de Senarclens B; Terrier P
    Rev Med Suisse Romande; 1977 Aug; 97(8):367-72. PubMed ID: 929024
    [No Abstract]   [Full Text] [Related]  

  • 27. Pindolol: a potent beta-adrenergic blocking agent in the treatment of hypertension.
    Jaroonvesma N; Charoenlarp K
    J Int Med Res; 1978; 6(6):435-40. PubMed ID: 363480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect on blood pressure of beta-adrenoreceptor-blocking drugs given once daily.
    Wilson M; Morgan G; Morgan T
    Clin Sci Mol Med Suppl; 1976 Dec; 3():527s-528s. PubMed ID: 1071674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
    Török E; Jávor T; Szám I; Gábor G
    Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined treatment with beta-receptor blocker pindolol and diureticum trichlormethiazidum in patients with essential hypertony in stadium II WHO (author's transl))].
    Zdichynec B
    Z Kardiol; 1977 Sep; 66(9):508-10. PubMed ID: 335687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pindolol once daily in the treatment of hypertension].
    Frithz G
    Lakartidningen; 1975 Aug; 72(33):3073-4. PubMed ID: 1165677
    [No Abstract]   [Full Text] [Related]  

  • 33. Pindolol in hypertension: twice-daily versus thrice-daily dosage.
    Waal-Manning HJ; Wood AJ
    Med J Aust; 1975 Aug; 2(7):274-5. PubMed ID: 1160793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hypertension in the elderly with pindolol and clopamide.
    Persson I
    J Am Geriatr Soc; 1978 Aug; 26(8):337-40. PubMed ID: 670620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of pindolol dosage in hypertension by automatic indirect BP monitoring.
    Sheps SG; Schirger A; Spiekerman RE; Harman TR; O'Brien PC; Kleven MK; Kremer-Simpson K
    Arch Intern Med; 1985 Jan; 145(1):54-7. PubMed ID: 3970647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients compliance in hypertension--the importance of number of tablets.
    Asplund J; Danielson M; Ohman P
    Br J Clin Pharmacol; 1984 May; 17(5):547-52. PubMed ID: 6375710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 38. Two-years' study with a combination of pindolol and clopamide ('Viskaldix') in patients with moderate hypertension.
    Török E; Wagner M; Erdélyi M; Maklári E
    Curr Med Res Opin; 1979; 6(3):193-200. PubMed ID: 520024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of therapy on renal impairment in essential hypertension.
    van Zyl A; Jennings AA; Byrne MJ; Opie LH
    S Afr Med J; 1992 Dec; 82(6):407-10. PubMed ID: 1465689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.
    van Brummelen P; Bühler FR; Amann FW; Bolli P
    Eur J Clin Pharmacol; 1982; 22(6):491-3. PubMed ID: 6127218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.